Characteristics of patients (pts) and prognostic factors across treatment lines (TL) in metastatic colorectal cancer (mCRC): An analysis from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

被引：2

作者：

Bachet, Jean-Baptiste

Chibaudel, Benoist

Rakez, Manel

Goldberg, Richard M.

Tebbutt, Niall C.

Van Cutsem, Eric

Haller, Daniel G.

Hecht, J. Randolph Randolph

Mayer, Robert J.

Lichtman, Stuart M.

Benson, Al

Sobrero, Alberto F.

Tabernero, Josep

Adams, Richard

Zalcberg, John Raymond

Grothey, Axel

Yoshino, Takayuki

Shi, Qian

De Gramont, Aimery

机构：

[1] Hop La Pitie Salpetriere, Paris, France

[2] Franco British Inst, Levallois Perret, France

[3] ARCAD Fdn, Stat Unit, Levallois Perret, France

[4] West Virginia Univ, Inst Canc, Morgantown, WV 26506 USA

[5] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Heidelberg, Vic, Australia

[6] Univ Hosp Gasthuisberg, Leuven, Belgium

[7] Katholieke Univ Leuven, Leuven, Belgium

[8] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[9] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[12] Northwestern Med, Chicago, IL USA

[13] IRCCS Osped Policlin San Martino, Genoa, Italy

[14] Vall dHebron Univ Hosp, Barcelona, Spain

[15] UVic UCC, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[16] Cardiff Univ, Cardiff, Wales

[17] Velindre Canc Ctr, Cardiff, Wales

[18] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[19] West Canc Ctr, OneOncol, Germantown, TN USA

[20] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[21] Mayo Clin, Rochester, MN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.3575

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3575

引用

页数：3

共 50 条

[41] Prospective analysis of the early modulation of plasma amphiregulin (AR) during treatment with cetuximab and irinotecan in irinotecan-refractory metastatic colorectal cancer (mCRC) patients (pts)
Cremolini, Chiara
Loupakis, Fotios
Antoniotti, Carlotta
Fioravanti, Anna
Orlandi, Paola
Salvatore, Lisa
Canu, Bastianina
Schirripa, Marta
Masi, Gianluca
Di Desidero, Teresa
Marmorino, Federica
Bergamo, Francesca
Zoratto, Federica
Bocci, Guido
Falcone, Alfredo
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[42] Primary (1°) tumor location as an independent prognostic marker from molecular features for overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB / SWOG 80405 (Alliance).
Venook, Alan P.
Ou, Fang-Shu
Lenz, Heinz -Josef
Kabbarah, Omar
Qu, Xueping
Niedzwiecki, Donna
Zemla, Tyler
Goldberg, Richard M.
Hochster, Howard S.
O'Neil, Bert H.
Sanoff, Hanna Kelly
Mayer, Robert J.
Bertagnolli, Monica M.
Blanke, Charles David
Innocenti, Federico
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[43] Impact of molecular markers status on treatment effects comparing EGFR and VEGF monoclonal antibodies (mAbs) in untreated metastatic colorectal cancer (mCRC): Pooled individual patient data (IPD) analysis of randomized trials from the ARCAD database
Karapetis, C. S.
Liu, H.
Sorich, M.
Fiskum, J.
Grothey, A.
Adams, R. A.
Venook, A.
Heinemann, V.
Lenz, H. J.
Yoshino, T.
Zalcberg, J. R.
Chibaudel, B.
Buyse, M. E.
De Gramont, A.
Shi, Q.
ANNALS OF ONCOLOGY, 2020, 31 : S426 - S426
[44] Single nucleotide polymorphism (SNP) analysis identifies potential prognostic and predictive biomarker in patients (pts) with metastatic colorectal cancer (mCRC) treated with regorafenib in the phase III CORRECT trial
Battaglin, F.
Zhang, W.
Skubala, A.
Arai, H.
Wang, J.
Soni, S.
Wang, Y. A.
Koechert, K.
Schulz, A.
Teufel, M.
Millstein, J.
Lenz, H. J.
ANNALS OF ONCOLOGY, 2020, 31 : S439 - S439
[45] Analysis of NRAS mutation as poor prognostic indicator and predictor of resistance to anti-EGFR monoclonal antibodies (anti-EGFRs) in metastatic colorectal cancer (mCRC) patients (pts)
Schirripa, Marta
Loupakis, Fotios
Cremolini, Chiara
Morvillo, Manfredi
Bergamo, Francesca
Zoratto, Federica
Salvatore, Lisa
Antoniotti, Carlotta
Marmorino, Federica
Sensi, Elisa
Lupi, Cristiana
Fontanini, Gabriella
De Gregorio, Veronica
Giannini, Riccardo
Basolo, Fulvio
Masi, Gianluca
Falcone, Alfredo
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[46] Pooled safety analysis from phase 3 studies of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC) and metastatic colorectal cancer (mCRC).
Van Cutsem, Eric
Hochster, Howard S.
Shitara, Kohei
Mayer, Robert J.
Ohtsu, Atsushi
Falcone, Alfredo
Yoshino, Takayuki
Doi, Toshihiko
Ilson, David H.
Arkenau, Hendrik-Tobias
George, Ben
McGuigan, Sandra
Makris, Lukas
Tabernero, Josep
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[47] Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients
Gu, Xiao-Dong
Cai, Yan-Tao
Zhou, Yi-Ming
Li, Zhen-Yang
Xiang, Jian-Bin
Chen, Zong-You
BMC CANCER, 2015, 15
[48] Prognostic factors and multidisciplinary treatment modalities for brain metastases from colorectal cancer: analysis of 93 patients
Xiao-Dong Gu
Yan-Tao Cai
Yi-Ming Zhou
Zhen-Yang Li
Jian-Bin Xiang
Zong-You Chen
BMC Cancer, 15
[49] The impact of late-line treatment on overall survival (OS) from the initiation of first-line chemotherapy (CT) for patients (pts) with metastatic colorectal cancer (mCRC): Updated analysis
Kawakami, T.
Yamazaki, K.
Go, H.
Masuishi, T.
Kawamoto, Y.
Kato, K.
Kumanishi, R.
Sawada, K.
Shirasu, H.
Yuki, S.
Yamamoto, K.
Yamanaka, T.
Komatsu, Y.
Muro, K.
Yasui, H.
ANNALS OF ONCOLOGY, 2020, 31 : S433 - S434
[50] Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database
Ozawa, Heita
Kotake, Kenjiro
Kobayashi, Hirotoshi
Sugihara, Kenichi
SURGERY TODAY, 2014, 44 (09) : 1643 - 1650

← 1 2 3 4 5 →